Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Assets (2016 - 2025)

Historic Assets for Dr Reddys Laboratories (RDY) over the last 14 years, with Q3 2025 value amounting to $6.2 billion.

  • Dr Reddys Laboratories' Assets rose 1166.96% to $6.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 billion, marking a year-over-year increase of 1166.96%. This contributed to the annual value of $5.8 billion for FY2025, which is 2459.95% up from last year.
  • According to the latest figures from Q3 2025, Dr Reddys Laboratories' Assets is $6.2 billion, which was up 1166.96% from $5.7 billion recorded in Q1 2025.
  • In the past 5 years, Dr Reddys Laboratories' Assets ranged from a high of $6.2 billion in Q3 2025 and a low of $3.6 billion during Q1 2021
  • Its 5-year average for Assets is $4.5 billion, with a median of $4.1 billion in 2023.
  • Per our database at Business Quant, Dr Reddys Laboratories' Assets crashed by 290.18% in 2022 and then skyrocketed by 3252.34% in 2024.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Assets stood at $3.8 billion in 2021, then dropped by 2.9% to $3.6 billion in 2022, then increased by 15.02% to $4.2 billion in 2023, then surged by 32.52% to $5.6 billion in 2024, then increased by 11.67% to $6.2 billion in 2025.
  • Its Assets was $6.2 billion in Q3 2025, compared to $5.7 billion in Q1 2025 and $5.6 billion in Q3 2024.